Frailty is a cluster of clinical syndromes, including declines in weight, strength, endurance, balance, physical activity, and walking performance, often found in older general populations [1] . As a health construct, it is independently predictive of falls, hospitalization, and death in older adults [1] . Prefrailty, a possibly reversible intermediate state, is also associated with adverse health outcomes but to a lesser extent [1] .
Human immunodeficiency virus (HIV)-infected individuals are at a higher risk of non-AIDS-related morbidity and mortality than HIV-uninfected individuals, despite receipt of HIV treatment. Studies found that HIV infection is associated with an increased risk of prefrailty/frailty phenotype, as defined by the Fried criteria [2] [3] [4] . It is speculated that HIV-infected individuals may undergo accelerated biological aging [4] . Meanwhile, research reveals that 30%-50% of HIV-infected persons have mild neurocognitive impairment despite receiving HIV treatment. Studies in the general population found that cognitive function is predictive of future frailty, and vice versa [5, 6] . Other conditions, such as depression and insomnia, often associated with frailty in older adults are more prevalent in the HIVinfected population [7, 8] . However, little research has been done to address these complex interactions in this population [4, 9] .
China updated its national HIV treatment guidelines in 2016 to provide combination antiretroviral treatment (cART) immediately after an individual receives an HIV diagnosis, regardless of their CD4 + T-cell count. It is anticipated that age-related health conditions and prefrailty/frailty will become a major health concern, but few studies have addressed these issues in China. Thus, this study investigated the frailty phenotype in HIV-infected individuals aged ≥40 years in China and compared findings to those for similar but HIV-uninfected individuals. Our aims were to (1) explore whether HIV infection was independently associated with prefrailty/frailty and, if so, (2) identify the factors that might account for the higher prevalence of prefrailty/frailty in HIV-infected individuals.
METHODS

Study Population
Using a cross-sectional design, from June 2014 to May 2015 we consecutively enrolled 345 HIV˗infected patients aged ≥ 40 years in Taizhou Prefecture of Zhejiang Province, eastern China, who have registered with the Chinese National Information System for AIDS Prevention and Control (CNISAPC). HIV-uninfected participants were recruited from 1216 persons who were receiving HIV voluntary counseling and testing or were undergoing routine physical examinations at the local Center for Disease Prevention and Control facility during the study period. For this article, the controls were randomly selected from this sample and frequency-matched to cases in a 1:1 ratio by sex, education level, and 5-year age categories. The study was approved by the Institutional Review Board of Fudan University, Shanghai, China. Written informed consent was obtained from all study participants.
Data Collection
Participants underwent standardized screening to determine demographic characteristics and medical history of chronic diseases and underwent physical examination to determine height, weight, waist circumference, and blood pressure. The cutoff of waist circumference for abdominal obesity was 85 cm for men and 80 cm for women. HIV-related information was extracted from CNISAPC.
Definitions
Frailty phenotype was assessed using the Fried criteria, with the exception of physical activity, for which we used the proxy described by Onen et al [9, 10] . Frailty was defined by the presence of at least 3 of the following 5 criteria: unintentional weight loss, self-reported low physical activity, self-reported exhaustion, weak grip strength, and slow walking time. The presence of 1 or 2 of the criteria was defined as prefrailty, and the absence of all 5 criteria was defined as nonfrail.
Chronic conditions asked about included hypertension, diabetes, cardiovascular diseases (eg, coronary artery disease), renal disease, and cancer. Comorbidity was the presence of ≥1 self-reported chronic diseases or conditions previously listed. Of note, hypertension was assessed and defined as a systolic blood pressure of ≥ 140 mm Hg or diastolic blood pressure of ≥ 90 mm Hg or as current use of antihypertensive drugs with previous diagnosis of hypertension.
Depressive symptoms were measured by the 10-item adapted version of the Zung Self-Rating Depression Scale (range, 0-40). The cutoff of 20 was chosen because the standard cutoff for defining clinical depression by use of the original 20-item scale (range 0-80) is 40.
Insomnia symptoms were measured on the basis of the following question from the Jenkins sleep questionnaire [11] : "Over the last month did you: (1) have trouble staying asleep, (2) have trouble falling asleep, (3) wake up too early and feel unable to get back to sleep, and (4) wake up several times per night and feel unable to get back to sleep?" The presence of insomnia symptoms was based on respondents' answering "on most nights" or "on every night" to ≥1 question.
Presence of neurocognitive impairment was assessed using the International HIV Dementia Scale (IHDS) and the Chinese version of Mini-Mental State Examination (MMSE) if they satisfied one of these 2 definitions. The cutoff score for defining neurocognitive impairment using the IHDS was 10. Educationadjusted cutoffs were used for MMSE: ≤19 for no formal education, ≤22 for primary school education, and ≤26 for junior school graduates or above [12] .
Statistical Analysis
Statistical analyses were performed using SAS software (version 9.11). Group comparisons were assessed using χ 2 analysis, the Fisher exact test, or analysis of variance, where appropriate.
We used ordinal logistic regression models to explore factors associated with three frailty categories (nonfrail, prefrail, and frail). Using ordinal models could increase the statistical power, given that few participants were in frail groups. Variables with a P value of < .15 in univariate analysis were included in final multivariable model. Backward selection was used, with retention at a P value of < .10. To avoid model selection bias due to collinearity between depressive and insomnia symptoms, each of the variables was included without the other in 2 separate backward stepwise models.
RESULTS
Participants Characteristics
Both groups were comparable by age, sex, education level, but HIV-infected individuals were more often underweight; had more neurocognitive impairment, depressive, and insomnia symptoms; were less often overweight/obese and had a waist circumference above the cutoff; and exercised less regularly (P < .05). About 32.8% of HIV-infected individuals received a diagnosis of HIV infection ≥ 4 years, and 87.0% were receiving treatment, with a median treatment duration of 26 months (Table 1) .
Prevalence and Characteristics of Frailty
HIV-infected individuals were more likely to be frail (6.1% vs 0.6%) and prefrail (28.1% vs 11.9%) than HIV-uninfected individuals (P < .01). In both groups, those classified as frail or prefrail reported higher levels of depressive symptoms and were more likely to have a low body mass index (BMI; calculated as the weight in kilograms divided by the height in meters squared), defined as <18.5, and to have insomnia symptoms (Table 1) . Furthermore, HIV-infected persons who were classified as frail or prefrail were more likely to be older, cognitively impaired, and have comorbidities but less likely to have a high BMI (ie, ≥24) than those classified as nonfrail.
Association Between HIV Infection and Frailty
Multivariable ordinal logistic regression analysis indicated that there was a significant association between HIV infection and prefrailty/frailty after adjustment for age, sex, education level, BMI, waist circumference above the cutoff, and comorbidity (odds ratio [OR], 3.79; 95% confidence interval [CI], 2.50-5.73; P < .001). By considering the potential indirect causal mechanism from HIV infection to prefrailty/frailty through intermediate variables, such as depressive symptoms, insomnia symptoms, and neurocognitive impairment, an additional model was performed to estimate the direct effect of HIV infection on prefrailty/frailty, after further adjustment for these variables. The association between HIV and prefrailty/frailty remained statistically significant but was attenuated (OR, 2.16; 95% CI, 1.36-3.43; P = .001). When restricted to participants without neurocognitive impairment and insomnia symptoms and with a score of depressive symptoms <20 (n = 376), the association between HIV and prefrailty/frailty was further attenuated and no longer statistically significant (OR, 1.65; 95% CI, .86-3.19; P = .133).
Correlates of Frailty Stratified by HIV-Infection Status
Owing to the collinearity between depressive and insomnia symptoms in the HIV-infected group (Table 2) , separate multivariable models were conducted. Depressive symptoms as a continuous variable and insomnia symptoms were significantly associated with a higher risk of prefrailty/frailty in multivariable models (models 1 and 2), but in multivariable model simultaneously controlling for both, only depressive symptoms as a continuous variable was significant (model 3). In all 3 models, having ≥1 comorbidity, having neurocognitive impairment, and ≥ 4 years since HIV diagnosis were significantly associated with higher risk of prefrailty/frailty. Other variables, such as low weight, overweight/obese, and regular exercise, were either significant or marginally significant in 3 multivariable models, but age was only significant in models 1 and 3.
In the HIV-uninfected group, only a current BMI of < 18.5 was significantly associated with higher risk of prefrailty/frailty (Supplementary Table 1 ). But a waist circumference cutoff for abdominal obesity of 90 cm for men and 85 cm for women was significantly associated with a higher risk of prefrailty/frailty (OR, 2.58; 95% CI, 1.20-5.57) in the above models.
DISCUSSION
The frailty prevalence of 6.1% in HIV-infected individuals is similar to estimates in some studies but lower than most other studies [2, 3, 9] . The variation is likely to be attributable to differences in study design, as well as in demographic and clinical characteristics of study participants. The extremely low prevalence of frailty in the HIV-uninfected group is possibly attributable to the recruitment of all participants from among persons who came to Center for Disease Control and Prevention sites to receive health services, rather than the general population, and thus persons with disabilities were not included. An interesting finding was that almost all frail HIV-infected participants had neurocognitive impairment, with more than half meeting the definition for depression. An earlier study reported a lower prevalence of neurocognitive impairment but a similar prevalence of depression in frail HIV-infected adults [9] . Yet, another study revealed that neurocognitive impairment and physical frailty were highly correlated, particularly in older persons, in the presence of depression [13] , which may explain an extremely high prevalence of neurocognitive impairment observed in the frail HIV-infected participants, given a higher prevalence of depression. The other possible explanation was that our sample was on average 10 years older than these previous samples.
Consistent with other findings [2] [3] [4] , we found that HIV infection was independently associated with prefrailty/ frailty. But this association was much attenuated after additional adjustment for neurocognitive impairment and depressive and insomnia symptoms. These, together with their independent associations with prefrailty/frailty in HIV-infected patients, suggesting that prefrailty/frailty in middle-aged and older HIV-infected individuals may be linked to cognitive impairment, depression, and insomnia. However, our study does not allow us to determine whether these are causes or consequences of prefrailty/frailty. Longitudinal studies are needed to better understand the mechanism of frailty in HIV-infected adults and whether interventions targeting psychological and cognitive functions can prevent or mitigate frailty.
We found that being overweight or obese was associated with lower risk of frailty for HIV-infected participants. This is consistent with an earlier study in the general population [14] . Prior research also found that being overweight or obese was associated with better immune recovery and slower HIV disease progression, which may reduce the risk of frailty [15] . As expected, lower weight and lack of exercise were associated with a higher prevalence of prefrailty/frailty [14] , partly because both are criteria for defining prefrailty/frailty. This study has some limitations. First, we studied a frailty-like phenotype rather than a clinically validated frailty phenotype. Second, as this was a cross-sectional study, causal mechanisms of these factors cannot be determined. Third, neurocognitive impairment was detected by IHDS and MMSE, rather than by a full battery of neurocognitive tests, and is thus subject to misclassification bias. We assumed that such misclassifications were nondifferentially. Fourth, use of ordinal regression models presented problems and the proportional odds assumption was not met for age and neurocognitive impairment in the HIV-infected group, and thus their associations with prefrailty might be overestimated. Despite the limitations mentioned, the strengths of the study are its relatively large sample size, the enrollment of a highly comparable control group, and adjustments for an extensive number of potential confounders.
In summary, our findings suggest that higher prevalence of prefrailty/frailty in HIV-infected individuals, compared with uninfected individuals, may be linked to neurocognitive impairment, depression, and insomnia. This further highlights the importance of assessing cognitive function and psychological health along with the assessment of frailty for older HIVinfected adults. Other longitudinal studies are needed to explore the evolution of prefrailty and frailty in HIV-infected population with and without neurocognitive impairment and/or depression to better understand the mechanism of frailty, as well as the cognitive and physical aging processes, in HIV-infected adults.
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